|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0010583,
umls-concept:C0026565,
umls-concept:C0039871,
umls-concept:C0040732,
umls-concept:C0079083,
umls-concept:C0344211,
umls-concept:C0376152,
umls-concept:C0439859,
umls-concept:C0547040,
umls-concept:C0600688,
umls-concept:C1516213,
umls-concept:C1880156
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1996-7-25
|
|
pubmed:abstractText |
To assess the clinical toxicity and outcome associated with a comprehensive supportive care approach in poor-risk breast cancer (BrCA) patients with high-dose chemotherapy (HDC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:ConnaghanD GDG,
pubmed-author:DevineS MSM,
pubmed-author:DixS PSP,
pubmed-author:GellerR BRB,
pubmed-author:HeffnerL TLT,
pubmed-author:HillyerC DCD,
pubmed-author:HollandH KHK,
pubmed-author:HughesL LLL,
pubmed-author:MillerR LRL,
pubmed-author:MooreM RMR,
pubmed-author:WingardJ RJR,
pubmed-author:WintonE FEF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1156-64
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8648370-Actuarial Analysis,
pubmed-meshheading:8648370-Adult,
pubmed-meshheading:8648370-Algorithms,
pubmed-meshheading:8648370-Antineoplastic Agents, Alkylating,
pubmed-meshheading:8648370-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8648370-Bone Marrow Transplantation,
pubmed-meshheading:8648370-Breast Neoplasms,
pubmed-meshheading:8648370-Carboplatin,
pubmed-meshheading:8648370-Combined Modality Therapy,
pubmed-meshheading:8648370-Cyclophosphamide,
pubmed-meshheading:8648370-Female,
pubmed-meshheading:8648370-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:8648370-Humans,
pubmed-meshheading:8648370-Lymphatic Metastasis,
pubmed-meshheading:8648370-Middle Aged,
pubmed-meshheading:8648370-Neoplasm Staging,
pubmed-meshheading:8648370-Prognosis,
pubmed-meshheading:8648370-Risk Factors,
pubmed-meshheading:8648370-Survival Analysis,
pubmed-meshheading:8648370-Thiotepa,
pubmed-meshheading:8648370-Transplantation, Autologous,
pubmed-meshheading:8648370-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.
|
|
pubmed:affiliation |
Bone Marrow Transplant Program, Emory University School of Medicine, Atlanta, GA, USA.
|
|
pubmed:publicationType |
Journal Article
|
